Angela D.
- Country
- Italy
- Department
- Oncologia Medica IRCCS Ca' Granda Osp. Maggiore
Research Overview
- Evaluation of Trastuzumab Deruxtecan and Fluoropyrimidine Versus Standard Chemotherapy in HER2-Positive Gastric or Gastroesophageal Cancer with Minimal Residual Disease
- Evaluation of Neoadjuvant Aspirin and Metformin in Combination with Induction Chemotherapy and Chemoradiotherapy for Locally Advanced Rectal Cancer
Data & Insights
Has run more than one trial at 10 of 49 partner sites.
Specializations
Gastrointestinal Oncology
The investigator specializes in treating advanced gastrointestinal malignancies, with particular emphasis on colorectal cancer and gastric/gastroesophageal cancers.
- Metastatic Colorectal Cancer Management
- Gastric Cancer Treatment Strategies
- Gastroesophageal Junction Tumors
Their research encompasses both early-stage and metastatic disease settings.
Targeted Therapies
The investigator focuses on innovative treatment approaches incorporating targeted biological agents and immunotherapy combinations.
- HER2-Targeted Treatments
- Anti-angiogenic Therapy
- Immunotherapy Integration
Their work explores novel therapeutic combinations for gastrointestinal cancers.
Precision Medicine
The investigator advances personalized treatment approaches through biomarker-driven patient selection and molecular diagnostics.
- Liquid Biopsy Applications
- Biomarker Analysis
- Treatment Response Monitoring
Their research integrates molecular profiling for treatment optimization.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.